N
NewAmsterdam Pharma Company N.V. (NAMS)
NGM – Real vaqt narxi. Valyuta: USD
38.89
-0.70 (-1.77%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
38.89
-0.70 (-1.77%)
Yopilishda: May 12, 2026, 4:00 PM EDT
NewAmsterdam Pharma Company N.V., kechki bosqichdagi biofarmatsevtika kompaniyasi, kardiyometabolik kasalliklarga chalingan bemorlarga g'amxo'rlikni yaxshilash uchun terapiyalarni ishlab chiqadi. Kompaniya Obicetrapibni ishlab chiqmoqda, bu og'iz orqali qabul qilinadigan, kam dozali xolesteril ester transfer proteini (CETP) ingibitori bo'lib, u turli klinik sinovlarda monoterapiya va ezetimib bilan kombinatsiyalangan terapiya sifatida LDL-C ni kamaytirish uchun ishlatiladi. Kompaniya, shuningdek, Altsgeymer kasalligi uchun 2a faza klinik sinovida bo'lgan Obicetrapibni ishlab chiqmoqda. NewAmsterdam Pharma Company N.V. Niderlandiyaning Naarden shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D. | Founder, Chief Scientific Officer, Member of Executive Board & Director |
| Dr. Marc Ditmarsch M.D. | Chief Development Officer |
| Dr. Michael Harvey Davidson FACC, Facp., M.D. | CEO, President & Executive Director |
| Mr. Bob Rambo | Executive Vice President of Marketing |
| Mr. Douglas F. Kling | Chief Operating Officer |
| Mr. Matthew Philippe | Executive VP &Head of Investor Relations |
| Mr. Mayur Amrat Somaiya | Chief Financial Officer |
| Ms. Juliette Audet M.B.A., M.Sc. | Chief Strategy & Business Officer |
| Ms. Louise Kooij | Chief Accounting Officer |
| Ms. Maryellen McQuade | Chief People Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | nams-20260507.htm |
| 2026-05-07 | 10-Q | nams-20260331.htm |
| 2026-05-06 | DEF 14A | nams-20260506.htm |
| 2026-05-06 | ARS | nams_2025_10-k_ars.pdf |
| 2026-04-24 | 8-K | nams-20260420.htm |
| 2026-04-20 | PRE 14A | nams-20260420.htm |
| 2026-03-02 | 8-K | nams-20260302.htm |
| 2026-02-18 | S-8 | nams-20260218.htm |
| 2026-02-18 | 8-K | nams-20260218.htm |
| 2026-01-09 | 8-K | nams-20260109.htm |